BROOKS
Brooks Laboratories Limited (BROOKS) Stock Analysis
Brooks Laboratories Limited is an Indian contract pharmaceutical manufacturer. It produces formulations and APIs for domestic and international pharma companies. CDMO relationships and regulatory compliance underpin its business in India. The company is listed on Indian stock exchanges and operates from India.
Healthcare › Drug Manufacturers - Specialty & Generic
₹70.10
+27.97% 1W | -52.90% 52W
Market Cap
207 CR
P/E Ratio
15.6
52W High
₹131.6
52W Low
₹36.3
Div. Yield
0%
Beta
1.1
50 DMA
₹61.4
200 DMA
₹63.7
Profit Margin
15.9%
Inst. Own.
9.9%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.70 | 24.32 | 21.75 | 17.72 | 17.93 | 20.79 | 20.52 | 23.32 | 25.51 | 23.45 | 16.57 | 20.21 | 22.96 |
| Expenses | 19.61 | 25.42 | 25.12 | 27.25 | 19.85 | 24.20 | 22.02 | 24.58 | 22.38 | 20.93 | 15.84 | 19.53 | 24.30 |
| Operating Profit | -3.91 | -1.10 | -3.37 | -9.53 | -1.92 | -3.41 | -1.50 | -1.26 | 3.13 | 2.52 | 0.73 | 0.68 | -1.34 |
| OPM % | -24.90% | -4.52% | -15.49% | -53.78% | -10.71% | -16.40% | -7.31% | -5.40% | 12.27% | 10.75% | 4.41% | 3.36% | -5.84% |
| Other Income | 0.05 | 0.09 | 0.16 | 0.65 | 0.07 | 0.20 | 0.03 | 0.62 | 7.15 | 6.13 | 5.32 | 1.35 | 0.18 |
| Interest | 0.17 | 0.19 | 0.21 | 0.27 | 0.16 | 0.32 | 0.28 | 0.26 | 0.30 | 0.28 | 0.16 | 0.09 | 0.21 |
| Depreciation | 0.44 | 0.44 | 0.43 | 0.46 | 0.40 | 0.43 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 | 0.41 | 0.42 |
| Profit before tax | -4.47 | -1.64 | -3.85 | -9.61 | -2.41 | -3.96 | -2.13 | -1.29 | 9.59 | 7.98 | 5.50 | 1.53 | -1.79 |
| Tax % | 0.00% | 0.00% | 0.78% | 0.00% | 0.00% | 0.00% | 0.00% | 13.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -4.47 | -1.64 | -3.88 | -9.61 | -2.41 | -3.96 | -2.13 | -1.46 | 9.58 | 7.98 | 5.50 | 1.52 | -1.79 |
| EPS in Rs | -1.71 | -0.62 | -1.48 | -3.66 | -0.92 | -1.51 | -0.81 | -0.50 | 3.25 | 2.71 | 1.87 | 0.52 | -0.61 |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 77 | 91 | 63 | 79 | 83 | 86 | 83 |
| Expenses | 77 | 105 | 93 | 97 | 91 | 79 | 81 |
| Operating Profit | 1 | -14 | -30 | -18 | -8 | 7 | 3 |
| OPM % | 0.7% | -16% | -47% | -22% | -10% | 8% | 3.1% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 20 | 13 |
| Interest | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 2 | 2 | 2 | 2 |
| Profit before tax | -9 | -24 | -38 | -20 | -10 | 25 | 13 |
| Tax % | 115% | -19% | -19% | 0% | 2% | 0% | |
| Net Profit | -19 | -19 | -31 | -20 | -10 | 25 | 13 |
| EPS in Rs | -7.40 | -4.31 | -7.97 | -7.46 | -3.38 | 8.34 | 4.49 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 11.0% | 2.0% | – |
| Profit CAGR | 47.0% | 27.0% | – |
Shareholding Pattern
Promoters52.62%
DIIs10.38%
Public37.00%
Promoters52.62%
FIIs0.01%
DIIs10.38%
Public37.00%
Promoters52.62%
FIIs0.09%
DIIs10.38%
Public36.91%
Promoters52.62%
FIIs0.17%
DIIs10.38%
Public36.84%
Promoters52.62%
DIIs10.38%
Public37.00%
Promoters66.41%
Public33.59%
Promoters63.59%
DIIs3.86%
Public32.55%
Promoters52.62%
FIIs0.05%
DIIs10.38%
Public36.95%
Promoters52.62%
FIIs0.17%
DIIs10.38%
Public36.84%
Promoters52.62%
DIIs10.38%
Public37.00%
BROOKS
Holdings Analysis
Key strengths & risk signals
62
Overall
53
Fundamental
72
Technical
Risks (4)
CAUTION! Company made loss in last quarter. Be careful.
POOR YEAR! Stock declined 52.9% in the last year.
BEARISH TREND! 50-day average (61.4) is below 200-day average (63.7) - negative signal.
LOWER HALF! Trading at 35.5% of 52W range - weakness visible.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BREAKOUT! Stock has broken above resistance levels with momentum.
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 254,128 vs down days: 38,734. Ratio: 6.56x
STRONG POSITION! Current price (70.1) is above both moving averages.
Fundamental & Technical Analysis
62Overall
53Fundamental
72Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 11.0% (GOOD, 11/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
6/10
GOOD EFFICIENCY! 15.9% profit margin - above average profitability.
PEG Valuation
9/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 33.58% public ownership - moderate retail influence.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (61.4) is below 200-day average (63.7) - negative signal.
Price Position
8/10
STRONG POSITION! Current price (70.1) is above both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
0/10
POOR YEAR! Stock declined 52.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 254,128 vs down days: 38,734. Ratio: 6.56x
RSI
3/5
BULLISH! RSI at 66.1 - positive momentum.
52W Range
2/5
LOWER HALF! Trading at 35.5% of 52W range - weakness visible.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 28.0% (1 week), 11.3% (1 month), -0.4% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.10 - moves with the market.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BROOKS | ₹70.10 | 15.6 | 15.9% | 11.0% | – | -52.9% | 62 | BREAKOUT | -118.8% | -220.0% | -9.8% | +13.9% |
| NECLIFE | ₹10.10 | 28.9 | – | – | – | -24.9% | 46 | BREAKDOWN | -75.6% | -77.3% | – | – |
| MEDICO | ₹22.80 | 13.7 | 5.8% | 13.8% | 21.9% | -55.7% | 55 | BREAKDOWN | +38.9% | -57.6% | +81.2% | +22.2% |
| NATCAPSUQ | ₹160.00 | – | -8.1% | 3.6% | – | -32.4% | 46 | BREAKDOWN | +1.8% | +14.0% | +7.7% | -16.8% |
| BALPHARMA | ₹93.10 | 20.5 | 2.2% | 0.1% | 34.7% | +18.7% | 66 | CONSOLIDATING UP | +450.0% | -69.4% | +34.4% | +5.4% |
| PAR | ₹117.10 | 11 | 13.3% | 11.0% | 1.0% | +21.6% | 66 | BREAKDOWN | +42.7% | +423.3% | +20.3% | +59.6% |
| BALAXI | ₹22.30 | 49.6 | 0.5% | -7.1% | -68.6% | -48.5% | 51 | APPROACHING SUPPORT | +333.3% | +116.7% | +14.1% | +14.1% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -16.8% | 47 | BREAKDOWN | -52.8% | +8.7% | +27.3% | +2.9% |
Data from TradeAlone · Updated daily
No news tagged for BROOKS yet.
